Envoy Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Envoy Medical (COCH).

Price Target Range — 8 Quarters

Analyst Consensus — 6 Analysts

6Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$50Upside to Avg. PT+668.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 27, 2026	Lake Street	Frank Takkinen	Maintained	Buy	$3→$25
Oct 6, 2026	Lake Street	Frank Takkinen	Initiate	Buy	$25
Aug 21, 2026	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$25→$20
Jul 27, 2026	LUCID CAPITAL MARKETS	Alex Nowark	Initiate	Buy	$20
Jul 15, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$25
Mar 31, 2026	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$25
May 27, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$93→$95
Apr 21, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$90→$93
Dec 6, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$88→$90
Oct 14, 2024	Brookline Capital	Tyler Bussian	Initiate	Buy	$90
Sep 3, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$85→$88
Jun 24, 2024	Ascendiant Capital	Edward Woo	Initiate	Buy	$85
Apr 3, 2024	Lake Street	Frank Takkinen	PT Raise	Buy	$30→$60
Dec 21, 2023	Northland Capital Markets	Carl Byrnes	Initiate	Outperform	—
Nov 28, 2023	Lake Street	Frank Takkinen	Initiate	Buy	$30

Analyst Ratings News

PRO
Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5

Lake Street analyst Frank Takkinen initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $2.5.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2

HC Wainwright & Co. analyst Yi Chen maintains Envoy Medical (NASDAQ:COCH) with a Buy and lowers the price target from $2.5 to $2.

Benzinga Newsdesk

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $2.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Envoy Medical, Maintains $2.5 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Envoy Medical (NASDAQ:COCH) with a Buy and maintains $2.5 price target.

Benzinga Newsdesk

This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR.

Avi Kapoor

This Shake Shack Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Monday

Avi Kapoor

Envoy Medical Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Envoy Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5

PRO
HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2

PRO
HC Wainwright & Co. Reiterates Buy on Envoy Medical, Maintains $2.5 Price Target

This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

This Shake Shack Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Monday

People Also Watch

People Also Watch

Envoy Medical Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Envoy Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5

PROHC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2

PROLUCID CAPITAL MARKETS Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2

PROHC Wainwright & Co. Reiterates Buy on Envoy Medical, Maintains $2.5 Price Target

This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

This Shake Shack Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Monday

People Also Watch

People Also Watch

PRO
Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5

PRO
HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2

PRO
HC Wainwright & Co. Reiterates Buy on Envoy Medical, Maintains $2.5 Price Target